دورية أكاديمية

Reducing morbidity and mortality in high risk patients with statins

التفاصيل البيبلوغرافية
العنوان: Reducing morbidity and mortality in high risk patients with statins
المؤلفون: Singh, Vibhuti, Deedwania, Prakash
المصدر: Vascular Health and Risk Management, vol Volume 5, iss 2
بيانات النشر: eScholarship, University of California
سنة النشر: 2009
المجموعة: University of California: eScholarship
مصطلحات موضوعية: Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Atherosclerosis, Clinical Research, Heart Disease - Coronary Heart Disease, Heart Disease, Cardiovascular, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Good Health and Well Being, Atorvastatin, Cardiovascular Diseases, Cholesterol, LDL, Coronary Disease, Diabetes Complications, Dose-Response Relationship, Drug, Heptanoic Acids, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Intracranial Arteriosclerosis, Kidney Failure, Chronic, Metabolic Diseases, Practice Guidelines as Topic, Pyrroles, Randomized Controlled Trials as Topic, Risk Factors, chronic kidney disease
جغرافية الموضوع: 495 - 507
الوصف: Residual coronary heart disease remains a significant problem even after adequate statin therapy for cardiovascular risk reduction as currently recommended by the Adult Treatment Panel III (ATP-III) of the National Cholesterol Education Program (NCEP). This is particularly true for the high risk patients as defined by ATP-III that includes those patients who have a greater than 20% 10-year risk of adverse cardiac events. For such patients the current goal of a low-density lipoprotein cholesterol (LDL-cholesterol) maintenance level of < or =100 mg/dL plasma appears to be suboptimal. Accumulating data from several recent randomized studies of more aggressive LDL-cholesterol reduction to levels below 70 mg/dL in the high risk patients favor acceptance of such a new lower target for LDL-cholesterol using more intensive statin therapy which would affect the treatment strategy for patients with coronary heart disease pre-percutaneous intervention, metabolic syndrome, diabetes mellitus, congestive heart failure, cerebrovascular disease and chronic kidney disease.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: unknown
العلاقة: qt84f3s2t4; https://escholarship.org/uc/item/84f3s2t4Test
الإتاحة: https://escholarship.org/uc/item/84f3s2t4Test
حقوق: public
رقم الانضمام: edsbas.245CF7B0
قاعدة البيانات: BASE